Intravascular large B-cell lymphoma(IVL) is a unique subtype of diffuse large B-cell lymphoma (DLBCL), characterized by systemic proliferation of neoplastic cells within the lumina of small to medium-sized vessels. IVL mainly affects older individuals, and associated with an aggressive clinical course (1) . It has been well known that IVL often involves the nervous system and/or skin, but rarely the bone marrow, lymph nodes, liver, or spleen. Non-specific clinical features, such as fever, malaise, dyspnea, and the absence of lymphadenopathy and mass formation, often cause diagnostic difficulties. B-cell lymphomaassociated with hemophagocytic syndrome (BCL-HS)is also characterized by the large cell morphology, aggressive clinical course, and rarity of lymphadenopathy, and has been reported almost exclusively in eastern Asia. In our critical appraisal of the cases with BCL-HSin Japan, we found the pathologic feature of an intravascular pattern constituting a clinically distinct variant of IVL. Therefore, this tumor was preferably designated as an Asian variant of IVL (AIVL) based on the clinical manifestations of hemophagocytic syndrome, but rare skin lesions or neurological abnormalities, features of which differ from the classical or prototypic IVL observed in Western countries (2) . AIVLalso has a myriad of clinical presentations including pyrexia, anemia, thrombocytopenia, respiratory disturbance, disseminated intravascular coagulation, hepatosplenomegaly, and in particular bone marrow involvement without lymphadenopathy (3). The incidence of IVL maybe not as rare as previously anticipated at least in Japan, and it may be influenced by the rapid rise of the aged men (>65 years old) in population. So far as we knowto date, over 200 cases with IVL have been already documented in Japan. In a MEDLINE search, two-third of these cases were after 1996. These documentations also revealed that many IVL cases had a delayed diagnosis, misdiagnosis or both, and often the clinical course was aggressive before the definite diagnosis was made.
The diagnostic criteria were recently proposed by the authors to better characterize the cases with AIVLand to make earlier diagnoses, which are briefly summarized in Table 1 (3) . By applying the criteria to the 67 Japanese cases with IVL in the literature, it was estimated that two-thirds (67%) of the cases should be clinically regarded as Asian variant (AIVL), while the other one-third was classified as classical or prototypic IVL (CIVL). It is also noteworthy that ante-mortem diagnosis was obtained only in 36% ofAIVL cases that was significantly inferior to 64% of CIVL. The median survival was 13 and 16 months for AIVLand CIVL patients, respectively, with the administration of chemotherapeutic regimens containing anthracycline (4). There continues to be a high mortality despite the treatment. Without chemotherapy, the median survival from the onset was only 4 months for the AIVLpatients (4). For the definite diagnosis of AIVL, bone marrowexamination is an essential diagnostic tool, since it is very frequently involved at presentation. Hepatosplenic involvement is also a commonfeature ofAIVL (3). However, the needle biopsy specimens obtained from bone marrowand liver often pose a diagnostic problem for clinicians and pathologists because of the paucity of the lymphomacells. The report by Yoshikawa et al in this issue suggests that splenectomy maybe a useful method for obtaining a definite diagnosis in the early stage ofAIVL (5) .
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Splenectomy usually is associated with some risk, especially when the general condition of the patient is poor. Nevertheless, this procedure, with wedge biopsy of the liver if possible, should be considered as one of the choices for obtaining a diagnosis of AIVL that is inevitably fatal without intensive chemotherapy. Special attention should be paid to an unusual redpulp and sinusoidal distribution of the lymphoma cells. Biopsies of the lung or kidney might also be warranted for consideration, especially when their dysfunction may exist (3 involving chromosomes 8p21 and 19ql3 were the most common in AIVL (3, 7) . Although some chronic inflammation such as tuberculous or helminthous infection might contribute to the onset ofAIVL, its pathogenesis is largely unknown (3, 8) .
Further investigation is needed in the future. In summary, many cases with AIVLhave likely been overlooked in Japan. The possibility of AIVL should always be considered in middle-aged or elderly patients with hemophagocytic syndrome, especially in Asia. To improve the prognosis of the AIVLpatients, the optimal strategy for treatment should urgently be established. 
